Shares in AbbVie slumped by double digits Monday after the company disclosed its psychiatric medicine emraclidine didn’t best ...

Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the ...

“As the industry transitions from traditional drug discovery and life sciences R&D to faster-paced, complex modalities, ...

The Food and Drug Administration has cleared Novavax to move forward with testing of a combination vaccine for COVID-19 and ...

Chicago, IL – Ellis Bio, a new biotech company spun out from The University of Chicago, officially launches this week with a mission to revolutionize epigenomics research. Founded by Professor Chuan ...

After Kalaris and AlloVir combine, the new company will have about $100 million to advance a treatment for age-related ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Past comments by Robert F. Kennedy Jr. hint at the ideas he might advocate for if given a role in the incoming Trump ...

On the heels of its most advanced medicine flunking a key study, the drugmaker is looking at the different paths it could ...

Sales of Moderna’s COVID-19 shot exceeded expectations, but the company’s launch of its new RSV vaccine has started slowly.

Elevidys sales have increased since the FDA made a controversial choice to expand the therapy's use. Meanwhile, Sarepta is ...

The president-elect has said he’ll let Robert F. Kennedy Jr. “go wild” on healthcare, while many expect a leadership change ...